Merck & Co. Total Stockholders' Equity Before Treasury Stock increased by 1.7% to $115.61B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.5%, from $104.62B to $115.61B. Over 5 years (FY 2020 to FY 2025), Total Stockholders' Equity Before Treasury Stock shows an upward trend with a 7.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth indicates strong internal capital generation and positive equity performance.
This metric represents the total book value of equity attributable to shareholders before accounting for the cost of rep...
Used by analysts to normalize equity comparisons across companies with different buyback histories.
total_stockholders_equity_before_treasury| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $89.98B | $93.04B | $95.29B | $97.95B | $100.01B | $101.22B | $102.48B | $103.41B | $95.31B | $98.31B | $95.03B | $97.81B | $100.98B | $102.33B | $104.62B | $107.74B | $109.49B | $113.65B | $115.61B |
| QoQ Change | — | +3.4% | +2.4% | +2.8% | +2.1% | +1.2% | +1.2% | +0.9% | -7.8% | +3.2% | -3.3% | +2.9% | +3.2% | +1.3% | +2.2% | +3.0% | +1.6% | +3.8% | +1.7% |
| YoY Change | — | — | — | — | +11.2% | +8.8% | +7.5% | +5.6% | -4.7% | -2.9% | -7.3% | -5.4% | +6.0% | +4.1% | +10.1% | +10.1% | +8.4% | +11.1% | +10.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.